Saturday 17 October 2026
Export MDRX’s income statement to Excel — free account
Veradigm Inc.
MDRX Healthcare Health Information Services
5.00
0.00
0.00%
Follow MDRX
| Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
1 | 8 | 7 | 5 | 6 | 5 | 7 | 5 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 17.08 | 3.11 | 0.00 | 4.57 | 0.00 | 0.00 |
P/S ratio |
1.86 | 2.05 | 3.28 | 4.16 | 4.14 | 1.00 | 1.05 | 1.81 | 1.47 |
Altman Z-Score |
1.65 | 2.64 | 3.73 | 2.39 | 1.70 | 0.76 | 1.05 | 0.76 | 0.78 |
P/FCF ratio |
12.92 | 14.25 | 22.83 | 0.00 | 0.00 | 0.00 | 0.00 | 22.13 | 14.06 |
Altman Z″-Score (non-manufacturers) |
2.15 | 4.91 | 5.43 | 3.20 | 2.62 | (0.31) | 0.94 | 0.11 | 0.37 |
Beneish M-Score |
(3.57) | (2.72) | (3.07) | (2.56) | (1.57) | (3.02) | (2.71) | (2.79) | (2.60) |
P/Operating CF |
51.90 | 57.22 | 91.66 | 37.60 | (13.10) | 132.67 | (124.20) | 25.50 | 24.27 |
P/B ratio |
1.07 | 1.18 | 1.90 | 1.77 | 1.38 | 1.27 | 1.07 | 2.34 | 1.60 |
Price to Tangible BV |
2.76 | 3.05 | 4.88 | 3.37 | 5.68 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.52 | 1.71 | 2.94 | 4.61 | 3.56 | 1.48 | 1.35 | 2.35 | 2.35 |
EV/EBITDA |
11.40 | 12.83 | 22.08 | 17.82 | 20.80 | 24.47 | 74.05 | 20.70 | 15.98 |
EV/Operating CF |
7.65 | 8.61 | 14.82 | (34.78) | (19.09) | 52.13 | 32.11 | 12.58 | 12.12 |
EV/FCF |
10.57 | 11.89 | 20.47 | (22.58) | (13.27) | (32.80) | (33.07) | 28.71 | 22.53 |
Quick Ratio |
0.95 | 1.25 | 2.46 | 0.52 | 0.97 | 0.46 | 0.81 | 0.70 | 0.75 |
Current Ratio |
1.29 | 1.57 | 2.95 | 1.33 | 1.23 | 0.69 | 1.08 | 0.96 | 0.91 |
Net Debt/EBITDA |
0.48 | (2.93) | (3.16) | 1.57 | (3.66) | 7.89 | 16.40 | 4.75 | 6.01 |
Debt/Assets |
16.78% | 13.04% | 13.32% | 16.01% | 6.50% | 28.56% | 20.98% | 22.14% | 34.50% |
Debt/Equity |
0.28 | 0.19 | 0.20 | 0.27 | 0.11 | 0.71 | 0.42 | 0.81 | 1.04 |
Asset Turnover |
0.41 | 0.41 | 0.31 | 0.22 | 0.18 | 0.51 | 0.44 | 0.37 | 0.43 |
Operating CF/Net income |
0.07 | 2.02 | (1.35) | (0.55) | (0.15) | (0.25) | 0.19 | (1.42) | (10.49) |
Capex/Depreciation |
(0.56) | (0.61) | (0.31) | (0.57) | (0.52) | (0.60) | (0.68) | (1.00) | (0.91) |
Interest Coverage |
(12.94) | 6.55 | (4.27) | 5.94 | 0.23 | (2.31) | (3.31) | 0.33 | 2.30 |
| (31.04%) | 4.70% | (7.27%) | 9.22% | 47.17% | (12.71%) | 26.55% | (16.15%) | (1.91%) | |
| (19.93%) | 3.20% | (4.53%) | 5.34% | 22.73% | (5.70%) | 9.82% | (4.87%) | (0.79%) | |
ROIC |
(16.52%) | 2.60% | (2.20%) | 3.01% | 0.38% | (3.02%) | (5.10%) | 0.40% | 1.69% |
Return on Tangible Assets |
(235.54%) | 19.42% | (18.85%) | 78.18% | 239.52% | 64.72% | 198.60% | (190.92%) | (29.81%) |
Average Days of Receivables |
66.09 | 64.82 | 73.96 | 75.66 | 244.67 | 94.89 | 104.97 | 120.04 | 106.70 |
Research and Development Expense of Revenue |
18.21% | 15.49% | 16.65% | 14.57% | 14.13% | 15.03% | 15.99% | 13.51% | 12.88% |
Selling, General and Administrative Expense of Revenue |
45.32% | 32.10% | 28.77% | 19.35% | 27.99% | 24.55% | 26.75% | 26.75% | 24.13% |
Intangible Assets out of Total Assets |
0.44 | 0.39 | 0.41 | 0.28 | 0.43 | 0.42 | 0.57 | 0.41 | 0.70 |
Share Based Compensation of Revenue |
4.13% | 2.60% | 4.27% | 2.04% | 1.93% | 2.39% | 2.14% | 2.44% | 2.68% |
Graham Net Nets |
0.18 | 0.16 | 0.10 | (0.13) | (0.04) | (0.66) | (0.44) | (0.82) | (0.96) |
Graham Number |
— | — | 0.00 | 15.94 | 33.05 | 0.00 | 20.65 | 0.00 | 0.00 |
Earnings Yield |
(7.90%) | (7.16%) | (4.47%) | 5.85% | 32.13% | (11.10%) | 21.89% | (7.28%) | (1.28%) |
Free Cash Flow Yield |
7.74% | 7.02% | 4.38% | (4.91%) | (6.48%) | (4.50%) | (3.88%) | 4.52% | 7.11% |
Revenue per Share |
5.49 | 5.83 | 5.25 | 4.44 | 3.49 | 9.82 | 9.19 | 8.28 | 7.44 |
Operating CF per Share |
(0.19) | 0.93 | 1.04 | (0.59) | (0.65) | 0.28 | 0.39 | 1.55 | 1.44 |
Capex per Share |
(0.28) | (0.27) | (0.29) | (0.32) | (0.28) | (0.72) | (0.76) | (0.87) | (0.67) |
Free Cash Flow per Share |
(0.46) | 0.65 | 0.75 | (0.91) | (0.94) | (0.44) | (0.37) | 0.68 | 0.78 |
Cash per Share |
2.72 | 4.16 | 4.00 | 1.04 | 3.37 | 0.83 | 1.05 | 0.72 | 0.52 |
Shareholders Equity per Share |
7.43 | 10.01 | 9.08 | 10.45 | 10.46 | 7.73 | 8.98 | 6.42 | 6.84 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.43 | 10.01 | 9.08 | 10.45 | 10.46 | 7.73 | 8.98 | 6.42 | 6.84 |
Free Cash Flow |
(50.21) | 70.14 | 84.56 | (118.00) | (149.04) | (73.51) | (65.91) | 122.42 | 144.72 |
Working Capital |
123.78 | 253.21 | 449.34 | 160.79 | 218.45 | (369.43) | 61.24 | (32.51) | (62.74) |
Capital Expenditures |
(30.18) | (29.37) | (32.27) | (41.38) | (45.39) | (119.77) | (133.80) | (157.00) | (124.29) |
Net Current Asset Value |
(2.65) | 200.75 | 192.43 | (301.43) | (98.15) | (1,079.29) | (742.09) | (2,212.97) | (1,954.62) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 34.71 | 249.17 | 0.00 | 0.00 | 281.53 | 48.16 |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.07 | 0.08 | 0.07 | 0.08 | 0.10 | 0.09 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 31.28 | 289.68 | 0.00 | 0.00 | 216.98 | 30.06 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 11.15 | 4.10 | 1.21 | 2.25 | 1.62 | 1.16 | 0.92 |
Cash ROIC |
(3.79%) | 4.06% | 5.08% | (6.33%) | (6.23%) | (3.14%) | (2.71%) | 5.49% | 5.38% |
Accounts Receivable Turnover |
5.43 | 5.44 | 4.92 | 2.35 | 1.40 | 3.67 | 3.38 | 3.34 | 3.78 |
Accounts Payable Turnover |
11.19 | 10.92 | 16.94 | 15.49 | 4.21 | 11.62 | 12.54 | 8.16 | 8.43 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
38.66 | 27.30 | 40.26 | 2.69 | 44.90 | 36.71 | 26.80 | 36.19 | 58.67 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
109.40 | 115.15 | 119.42 | 246.24 | 398.60 | 444.84 | 478.91 | 448.87 | 366.51 |
Average Payables |
26.11 | 26.06 | 16.51 | 19.04 | 69.36 | 87.99 | 79.46 | 105.95 | 93.07 |
Average Assets |
1,462.58 | 1,538.80 | 1,907.87 | 2,614.32 | 3,061.68 | 3,193.61 | 3,705.82 | 4,031.15 | 3,257.05 |
Average Common Equity |
939.21 | 1,045.97 | 1,188.94 | 1,513.31 | 1,475.72 | 1,432.81 | 1,370.25 | 1,216.64 | 1,346.14 |
Columns are period end dates · fundamentals updated 1 Oct 2026